This inventor holds 1 USPTO granted patent. Top assignee: Cytosorbents Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Karl-Gustav Ruggeberg
Introduction
Karl-Gustav Ruggeberg is an accomplished inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of novel absorbent materials for blood treatment.
Latest Patents
Ruggeberg holds a patent for "Crosslinked polysaccharide based absorbents for removal of anti-A and/or anti-B antibodies from human plasma and whole blood." This invention focuses on polymeric media derived from modified natural polysaccharides. The media is designed to effectively remove Anti-A and Anti-B antibodies from human blood or plasma. The invention includes a polymeric solid support with a blood group A Antigen ligand or a blood group B Antigen ligand, both of which are stable under physiological pH conditions.
Career Highlights
Ruggeberg is associated with Cytosorbents Corporation, where he applies his expertise in developing innovative solutions for blood purification. His work has the potential to improve patient outcomes in transfusion medicine and organ transplantation.
Collaborations
Ruggeberg collaborates with talented professionals such as Tamaz Guliashvili and Maryann Gruda, contributing to a dynamic research environment focused on advancing medical technologies.
Conclusion
Karl-Gustav Ruggeberg's innovative work in the field of absorbent materials showcases his commitment to improving healthcare solutions. His contributions are paving the way for advancements in blood treatment technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile